DNER and hepatocellular carcinoma: These findings thus suggest that simultaneously application of BET inhibitors and Oridonin may be more efficiently in killing HCC cells, which suggest that this strategy could be used to improve efficacy, to prevent tumor relapse and to inhibit metastasis in the treatment of HCC.